References
- Levine RJ, Hauth JC, Curet LB, et al. Trial calcium to prevent pre-eclampsia. N Engl J Med 1997;337:69–76
- Abalos E, Cuesta C, Carroli G, et al. Pre-eclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health. BJOG 2014;121:14–24
- Report of the National High Blood Pressure Education. Program Working Group Report on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183:S1–22
- Parra M, Rodrigo R, Barja P, et al. Screening test for preeclampsia through assessment of uteroplacental blood flow and biochemical markers of oxidative stress and endothelial dysfunction. Am J Obstet Gynecol 2005;193:1486–91
- Pijnenborg R. The placental bed. Hypertens Pregnancy 1996;15:7–23
- Zhou Y, Fisher SJ, Janatpour M, et al. Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? J Clin Invest 1997;99:2139–51
- Kaufmann P, Black S, Huppertz B. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod 2003;69:1–7
- Christopher WG, Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999;180:499–506
- Readman CW, Sargent IL. Lasted advances in understanding preeclampsia. Science 2005;308:1592–4
- Hayashi M, Ueda Y, Yamaguchi T, et al. Tumor necrosis factor-alpha in the placenta is not elevated in preeclamptic patients despite its elevation in peripheral blood. Am J Reprod Immunol 2005;53:113–19
- Kupferminc MJ, Pearceman AM, Wigton TR, et al. Tumor necrosis factor-α is elevated in plasma and amniotic fluid patients with severe preeclampsia. Am J Obstet Gynecol 1994;170:1752–7
- Yoshizumi M, Perrella MA, Burnett JC, Lee MET. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shorting its half-life. Circ Res 1993;73:205–9
- Teixeira-Salum TB, Rodrigues DB, Gervásio AM, et al. Distinct Th1, Th2 and Treg cytokines balance in chronic periapical granulomas and radicular cysts. J Oral Pathol Med 2010;39:250–6
- Pizano AL, Zamudio JL, Ortega VF, et al. The predominant Th1 cytokine profile in maternal plasma of preeclamptic women is not reflected in the choriodecidual and fetal compartments. J Soc Gynecol Investig 2005;12:335–42
- Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interations in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon? Immunol Today 1993;14:353–6
- Benyo DF, Samarason A, Redman CW, et al. Expression of inflammatory cytokines in placentas from women with preeclampsia. J Clin Endocrinol Metab 2001;86:2505–12
- Hung TH, Jones DS, Skepper JN, Burton GJ. Secretion of tumor necrosis factor-α from human placental tissues induced by hypoxia-reoxigenation causes endothelial cell activation in vitro. Am J Pathol 2004;164:1049–61
- Munno I, Chiechi LM, Lacedra G, et al. Spontaneous and induced release of prostaglandins, interleukin (IL)-1 beta, IL-6, and tumor necrosis factor alfa by placental tissue from normal and preeclamptic pregnancies. Am J Reprod Immunol 1999;42:369–74
- Banerjee S, Smallwood A, Moorhead J, et al. Placental expression of Interferon-gamma (IFN-gamma) and its receptor IFN-gamma R2 fail to switch from early hypoxic to late normotensive development in preeclampsia. J Clin Endocrinol Metab 2005;90:944–52
- Shaamash AH, Elsonosy ED, Zakhari MM, et al. Placental nitric oxide synthase (NOS) activity and nitric oxide (NO) production in normal pregnancy, preeclampsia and eclampsia. Int J Gynecol Obstet 2001;72:127–33
- Norris LA, Higgins JR, Darling MR, et al. Nitric oxide in the uteroplacental, fetoplacental and peripheral circulations in pre-eclampsia. Obstet Gynecol 1999;93:958–63
- Kim YJ, Park HS, Lee HY, et al. Reduced l-arginine level and decreased placental eNOS activity in preeclampsia. Placenta 2006;27:438–44